Medical Advocates
HIV Infection/Disease
  Adipose Tissue Metabolic Disorders  
Adipose Tissue Alterations: General
Abdominal Obesity
 Dyslipidemia
 Fat Redistribution
Hypoadiponectinemia 
Hyperlipidemia
Lipoatrophy
Lipohypertrophy
 

 
HIV Metabolic Disorders Main Page   Main New/Newsworthy Home Page  
Last Update: February 11, 2015
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader.
Adipose Tissue Alterations: General
       

        Journal Papers, Abstracts, and Commentaries

 

Bariatric surgery: An HIV-positive patient’s successful journey.
Eddy F, Elvin S, Sanmani L.
 Int J STD AIDS. 2015 Feb 6.
 Abstract

Obesity in HIV-infected patients in France: Prevalence and surgical treatment options.
Pourcher G, Costagliola D, Martinez V.
 J Visc Surg. 2015 Feb 4.
Abstract

Multiple frequency bioimpedance is an adequate tool to assess total and regional fat mass in HIV-positive patients but not to diagnose HIV-associated lipoatrophy: a pilot study.
Pérez-Matute P, Pérez-Martínez L, Blanco JR,
J Int AIDS Soc. 2013 Dec 27;16:18609.
 Abstract

CD8 T-cell activation is associated with lipodystrophy and visceral fat accumulation in ART-treated virologically-suppressed HIV-infected patients.
Guaraldi G, Luzi K, Bellistrì GM,  et al 
J Acquir Immune Defic Syndr. 2013 Oct 14.
Abstract

Surrogate markers of visceral adipose tissue in treated HIV-infected patients: accuracy of waist circumference determination.
Falutz J, Rosenthall L, Kotler D, et al
HIV Med. 2013 Sep 22.
Abstract

In Vitro and In Vivo Effects of IGF-I on Adiposity in HIV-associated Metabolic Disease: A Pilot Study.
Kim RJ, Vaghani S, Zifchak LM, et al
 Arch Med Res. 2013 Jul 15
 Abstract

Central/Peripheral Fat Mass Ratio Is Associated With Increased Risk of Hypertension in HIV-Infected Patients.
Freitas P, Carvalho D, Santos AC,  et al
J Clin Hypertens (Greenwich). 2012 Sep;14(9):593
 Abstract

Obesity and the risk and outcome of infection.
Huttunen R, Syrjänen J
 Int J Obes (Lond). 2012 May 1
 Abstract

Management of Fat Accumulation in Patients with HIV Infection.
Falutz J.
 Curr HIV/AIDS Rep. 2011 Jul 8..
 Abstract

Adipose Tissue as a Target of HIV-1 Antiretroviral Drugs. Potential Consequences on
Metabolic Regulations.
Caron-Debarle M, Boccara F, Lagathu C,  et al
Curr Pharm Des. 2010 Aug 5
 Abstract

Treatment Options for HIV-Associated Central Fat Accumulation.
Cofrancesco J, Freedland E, McComsey G. 
AIDS Patient Care STDS. 2008 Dec 4.
 Abstract
 
Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy –
associated lipodystrophy.
Sevastianova K, Sutinen J, Kannisto K, et al
Am J Physiol Endocrinol Metab. 2008 Apr 22
Abstract
 
HIV and HIV treatment: effects on fats, glucose and lipids.
Gkrania-Klotsas E, Klotsas AE.
Br Med Bull. 2007 Nov 2
 Abstract
 
Ultrasonography and Anthropometry for Measuring Regional Body Fat in HIV-Infected
Patients.
Padilla S, Gallego JA, Masiá M, et al
 Curr HIV Res. 2007 Sep;5(5):459-66.
Abstract
 
Strategies in the treatment of HIV-1-associated adipose redistribution syndromes.
Mar Gutierrez MD, Mateo G, Domingo P.
 Expert Opin Pharmacother. 2007 Aug;8(12):1871-1884.
 Abstract
 
Long-Term Body Fat Outcomes in Antiretroviral-Naive Participants Randomized to Nelfinavir
or Efavirenz or Both Plus Dual Nucleosides: Dual X-Ray Absorptiometry Results From A5005s,
a Substudy of Adult Clinical Trials Group 384.
Dubé MP, Komarow L, Mulligan K, et al
J Acquir Immune Defic Syndr. 2007 Jun 21;
 Abstract
 
Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based
highly active antiretroviral therapy.
 Chaparro J, Reeds DN, Wen W, et al
Metabolism. 2005 May;54(5):561-7
 Abstract
 
Chronic loss of subcutaneous adipose tissue in HIV-associated lipodystrophy may not
be associated with accelerated apoptosis.
Mynarcik D, Wei LX, Komaroff E, et al 
J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):367-71.
Abstract
 
Interventions for visceral adiposity associated with human immunodeficiency virus:
application of a method for assessing efficacy.
Engelson ES.
Clin Infect Dis. 2003;37 Suppl 2:S96-100.
 Abstract

Incidence of Adipose Tissue Alterations in First-Line Antiretroviral Therapy:
The LipoICoNa Study.
Galli M, Cozzi-Lepri A, Ridolfo AL, et al.
Arch Intern Med 2002 Dec 9;162(22):2621-8
 Abstract

Use of a Durnin-Womersley formula to estimate change in subcutaneous fat
content in HIV-infected subjects.
Andrade S, Lan SJ, Engelson ES, et al.
 Am J Clin Nutr 2002 Mar;75(3):587-92
 Abstract

Evidence of nucleoside analogue reverse transcriptase inhibitor–associated
genetic and structural defects of mitochondria in adipose tissue of HIV-infected
patients.
Walker UA, Bickel M, Lutke Volksbeck SI, et al.
J Acquir Immune Defic Syndr 2002 Feb 1;29(2):117-21
 Abstract

Long-term changes in adipose tissue in human disease.
Pond CM.
Proc Nutr Soc 2001 Aug;60(3):365-74
 Abstract

 

         Conference Reports, Abstracts, and Posters

 
Peri-renal fat diameter is related to intima media thickness and renal arterial resistance index in
HIV-1 infected patients
Grima PF, Chiavaroli R, Grima P, et al 
(Ninth International Congress on Drug Therapy in HIV Infection)
 Abstract
 
Low Levels of Lipin mRNA Expression in Adipose Tissues from HIV-infected
Patients with Lipodystrophy
B Lindegaard, L Frydelund-Larsen
(15IAC)
 Abstract

HIV-associated lipomatosis. An emerging adverse event of antiretroviral treatment,
related to dysmetabolism?
R Manfredi, L Calza, F Chiodo
 (15IAC)
 Abstract
 
Antiretroviral Therapy (ART)-Associated Adipose Tissue Alterations in Women:
a Prospective Study
(41ICAAC)
 Abstract		  

Abdominal Obesity
       
        Journal Papers, Abstracts, and Commentaries

 
  Effects of Testosterone Supplementation on Whole Body and Regional Fat Mass and
Distribution in HIV-Infected Men with Abdominal Obesity.
Bhasin S, Parker RA, Sattler F, et al
 J Clin Endocrinol Metab. 2006 Dec 12
 Abstract

Hypoadiponectinemia
       

Journal Papers, Abstracts, and Commentaries
 

  Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia,
and fat redistribution in human immunodeficiency virus-infected patients treated
with highly active antiretroviral therapy.
Addy CL, Gavrila A, Tsiodras S, et al.
J Clin Endocrinol Metab 2003 Feb;88(2):627-36
 Abstract

Lipohypertrophy
       

        Journal Papers, Abstracts, and Commentaries

  Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy
are associated with serum concentrations of leptin.
Nagy GS, Tsiodras S, Martin LD, et al.
Clin Infect Dis 2003 Mar 15;36(6):795-802
 Abstract		  

 
HIV Metabolic Disorders Main Page   Main New/Newsworthy Home Page  

Adipose Tissue Metabolic Disorders